<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/AF1FCF98-BB6B-4DB2-8892-4AE5FB22A2C2"><gtr:id>AF1FCF98-BB6B-4DB2-8892-4AE5FB22A2C2</gtr:id><gtr:firstName>Robert Alexander</gtr:firstName><gtr:surname>Weale</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/2761A603-5EF4-4006-8C7C-FBD7F3D90FC5"><gtr:id>2761A603-5EF4-4006-8C7C-FBD7F3D90FC5</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Hardy</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901254"><gtr:id>02DA11FC-EA88-46B3-8AF5-B9508172E2DD</gtr:id><gtr:title>Mapping the genetic architecture of global gene and exon expression in the human brain to understand common diseases</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901254</gtr:grantReference><gtr:abstractText>Diseases affecting the brain are common and often devastating. Unfortunately, we know relatively little about why certain people suffer from psychiatric conditions like schizophrenia, or neurological conditions like Alzheimer?s and Parkinson?s disease. However, in the past 3 years scientists have been able to show that some individuals inherit risk factors in their DNA, which make them more likely to develop these conditions. Although this has been an amazing step forward, because most of the inherited risk factors are not within the part of the DNA that codes for proteins we still do not understand how these risk factors change the way cells in the brain behave to cause disease. Without this type of information we cannot begin to develop new and more effective treatments. 
The aim of our work is to fill this gap in knowledge by investigating how inherited risk factors influence gene expression in the human brain so that we can better understand the causes of neurological and psychiatric disease. We hope to identify genetic variants in the DNA which not only increase the risk of having a disease of the brain, but also affect gene expression in brain regions already known to be important in disease. In this way we can start to pinpoint the systems or pathways in brain cells, which are causing the problem and hopefully provide the basic information that will lead to new treatments.
In this study we will use human brain tissue that has been donated for research by the deceased?s family to study the effect of inherited risk factors on the quantity and type of gene expression in different areas of the brain. We will use microarray technology to obtain detailed genetic and gene expression information about human brain tissue. The huge amount of information generated will be carefully analysed. The information this study will produce is likely to be of use to many researchers investigating a wide range of different diseases of the brain. Therefore, we will make sure that the results are made publicly available as soon as possible, while at the same time ensuring that information that could be used to identify individuals is protected.
Thus, we hope to be able to improve the understanding of the molecules and pathways that cause diseases of the brain and provide the basis for new treatments for diseases like Parkinson?s or schizophrenia.</gtr:abstractText><gtr:technicalSummary>The aim of this project is to translate newly discovered genetic risk traits for complex neurological and psychiatric conditions into an understanding of pathogenesis. Until recently there seemed little hope of developing a genetic understanding of common diseases of the central nervous system (CNS). However, whole genome association studies of human disease are revolutionising our understanding of the aetiology of complex diseases, from psychiatric conditions such as drug addiction and schizophrenia on the one hand, to neurological conditions like Parkinson?s and Alzheimer?s disease on the other. These studies have demonstrated what has long been suspected, that common ?normal? variability contributes to the risk of common neurological and psychiatric disease. While some of the risk loci identified have been assigned to coding changes in genes, the majority have not, and many have not even mapped to recognisable genes.

Thus, knowing genetic risk variants for common diseases has not provided an automatic understanding of pathogenesis or obvious therapies. In order to address this problem we will study the genetic variability of gene expression within the human brain. The basis of our approach is the hypothesis that genetic differences in transcriptional regulation, which are present and measurable in control populations, are important drivers of pathology in the human CNS. If common genetic differences in transcriptional regulation can drive pathology in the human CNS, then we would expect to find strong associations between the risk SNPs identified in GWAs for neurological and psychiatric diseases and specific mRNA expression phenotypes of functional significance in control human brain.

We intend to use post-mortem control human brain tissue to collect samples from well-defined brain regions known to be particularly affected in the most common neurological and psychiatric diseases. Since risk-associated SNPs will be present in the control as well as the case population, using control brain tissue we can study downstream affects on gene expression without the complications of neuronal death, glial response and symptomatic treatments. Using microarray technology, we will produce high quality, genome-wide paired SNP and exon-specific expression data. Data analysis will be focused on identifying downstream gene expression changes associated with individual SNPs known to increase the risk of developing a neurological or psychiatric disease.

Thus, we will bridge the gap between genetic risk and pathophysiology. In this way, we will be able to point towards new therapeutic strategies for the early and effective treatment of human diseases of the CNS.</gtr:technicalSummary><gtr:fund><gtr:end>2013-05-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1000509</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Laboratory of Neurogenetics</gtr:department><gtr:description>Whole genome expression database</gtr:description><gtr:id>8EC6C820-894B-4764-A319-29214FDDE075</gtr:id><gtr:impact>Just search Ryten plus Singleton on pubmed
These are the current PMID
23223016, 23177596, 22892372 , 22777693, 22723018, 22433082, 21738488 , 21292315</gtr:impact><gtr:outcomeId>dqs5q7xdifx-1</gtr:outcomeId><gtr:partnerContribution>We worked with our Us collaborators on this project (Singleton/Cookson): about half the work each</gtr:partnerContribution><gtr:piContribution>We are just abouhttp://bit.ly/braineac (ignore certificate warning)
username: UKBEC
password: BraineacNOW
t to relase this database to the general public</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>World Congress of Brain, Behavior and Emotions, Porto Alegre, Brazil</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C12292E5-7A9E-4173-9274-5454C6267962</gtr:id><gtr:impact>Talk entitled &amp;quot;The amyloid hypothesis for Alzheimer's disease: a critical reappraisal&amp;quot;. Deep discussion ensued following talk.

Exchange of in-depth emails regarding Prof Hardy's presentation and key ideas.</gtr:impact><gtr:outcomeId>565c689017ee53.54773592</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Genomic analysis of neurodegenerative disease</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>AAAAF189-0721-489E-B7A6-CBF2135AC963</gtr:id><gtr:impact>Talk given at the following events:

- Nuffield Department of Clinical Neurosciences monthly seminar series, John Radcliffe Hospital, Oxford, 26/03/2015
- Federation of European Neuroscience Societies (FENS) Summer School, Bologna, Italy, 07/06/2015
- Annual Symposium of the Korean Academy of Science and Technology (KAST), Seoul, South Korea, 12/11/2015

In-depth discussion following the talks. Approached by potential collaborators.</gtr:impact><gtr:outcomeId>565c65b39cc845.41219425</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>keynote/invited speaker</gtr:presentationType><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Methusalem Lecture, Leuven, Belgium: The genetics of neurodegenerative disorders</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4E1EFC78-3D0E-4B2C-91DA-9B432A82E5B0</gtr:id><gtr:impact>This was two lectures, one to professionals and one to care-givers on the molecular biology of neurodegenerative diseases.</gtr:impact><gtr:outcomeId>56e7dcfaea5ae9.88663224</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:url>http://www.vib.be/en/research/scientists/Pages/John-Hardy-public-lecture.aspx</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2010-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:id>0D847552-094D-4E81-8AA0-1DF687DAE761</gtr:id><gtr:outcomeId>WHpYh8VqDJk0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Gene expression data from the Mouse Dementia Network (Mouse DemNet).

The aim of Mouseac is to provide to the scientific community an easy to use tool to investigate gene expression changes in a number of mouse models of dementia across their lifespan relating to neurodegenerative disorders such as Alzheimer's disease.

Mouseac is an interface that provides access to the dataset presented in Matarin et al [http://dx.doi.org/10.1016/j.celrep.2014.12.041]. The aim of Mouseac is to provide a tool with which to explore the dataset resulting from a genome-wide microarray of genes expressed in 3 brain regions across 4 ages in 5 transgenic mouse models of dementia and their wild-type counterparts.

Detailed methodology can be found in the main manuscript.

All procedures were performed in agreement with the UK Animals (Scientific Procedures) Act, 1988, under HO PPL licence 70/7279 with local ethical agreement and following the GlaxoSmithKline statement on the use of animals.</gtr:description><gtr:id>01FBE986-408F-4395-875E-FE8C1728B5F9</gtr:id><gtr:impact>Open access research paper published in Cell Reports:
Matarin M, Salih DA, Yasvoina M, Cummings DM, Guelfi S, Liu W, Nahaboo Solim MA, Moens TG, Paublete RM, Ali SS, Perona M, Desai R, Smith KJ, Latcham J, Fulleylove M, Richardson JC, Hardy J, Edwards FA. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 2015 Feb;10(4) 633-644. doi:10.1016/j.celrep.2014.12.041. PMID: 25620700.

By creating the website at http://www.mouseac.org/, all the data has been made freely available for scientists and the general public to use.</gtr:impact><gtr:outcomeId>56587fe4d12d71.47801088</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouseac - Web server for data from the Mouse Dementia Network</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.mouseac.org/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput><gtr:researchDatabaseAndModelOutput><gtr:description>The Brain eQTL Almanac (Braineac) is a web-based resource to access the UK Brain Expression Consortium (UKBEC) dataset. The aim of Braineac is to release to the scientific community a valid instrument to investigate the genes and SNPs associated with neurological disorders.

What is possible with BRAINEAC?

- Visualise gene expression across the brain
- SNP acting as cis-eQTL on a selected gene and know where it's located
- Find if a one or more risk SNPs are operating as a eQTL and in which brain region
- Download the expression data by genes or tissue to develop new methods</gtr:description><gtr:id>B7E5481A-A3A1-4B01-8C75-7B7E787BF075</gtr:id><gtr:impact>http://www.nature.com/neuro/journal/v17/n10/full/nn.3801.html</gtr:impact><gtr:outcomeId>546dba7bba6f61.80571262</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Braineac - The Brain eQTL Almanac</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.braineac.org/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Gene expression database.

http://caprica.genetics.kcl.ac.uk:51519/BRAINEAC/</gtr:description><gtr:id>44132C11-6CDD-4A58-9101-EE1CEA986485</gtr:id><gtr:impact>It has been accessed several thousand times and data from it incorporated into at least 100 publications</gtr:impact><gtr:outcomeId>Wb8yNb7u8e4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human genome expression database</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:url>http://smarturl.it/braineac</gtr:url><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Database of gene expression in pathological mouse brain</gtr:description><gtr:id>16A44234-95F5-476C-9272-D4D2264B4A0B</gtr:id><gtr:impact>This web resource of mouse gene expression is accessed 50 times per week and has referred to about 300 further publications</gtr:impact><gtr:outcomeId>56e973e4d6bda2.69137297</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouseac</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type><gtr:url>http://www.mouseac.org/</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>B8D7EDED-433F-468E-9119-77CF4039F569</gtr:id><gtr:title>Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed587de899b30ad5f3dce3fc99e9d0a"><gtr:id>5ed587de899b30ad5f3dce3fc99e9d0a</gtr:id><gtr:otherNames>Keller MF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16043_23_22892372</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7A6DC0A-F42D-4D96-B0EB-A21318B62EEA</gtr:id><gtr:title>TOMM40 association with Alzheimer disease: tales of APOE and linkage disequilibrium.</gtr:title><gtr:parentPublicationTitle>Archives of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f54cad0ab0877e543fc660186cd44ff0"><gtr:id>f54cad0ab0877e543fc660186cd44ff0</gtr:id><gtr:otherNames>Guerreiro RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-9942</gtr:issn><gtr:outcomeId>pm_16043_23_22869030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BE8BE03A-20B1-4787-9774-14307259636B</gtr:id><gtr:title>Genome-wide association study of Tourette's syndrome.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/045c7ec333f69f0a159e3c0e5f7b66f6"><gtr:id>045c7ec333f69f0a159e3c0e5f7b66f6</gtr:id><gtr:otherNames>Scharf JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_16043_23_22889924</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D449865-CDF3-4F8F-92EB-2D06056328D9</gtr:id><gtr:title>Common variants at 12q14 and 12q24 are associated with hippocampal volume.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9bde7758d4db768ae0610c275fbb9a93"><gtr:id>9bde7758d4db768ae0610c275fbb9a93</gtr:id><gtr:otherNames>Bis JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16043_23_22504421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E926C090-33DE-445B-AC18-DA241B052DEA</gtr:id><gtr:title>Insights into TREM2 biology by network analysis of human brain gene expression data.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/05229e5e9f0a501fa7e63a396d570040"><gtr:id>05229e5e9f0a501fa7e63a396d570040</gtr:id><gtr:otherNames>Forabosco P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16043_23_23855984</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFAA5906-52F0-4C4D-980E-9FABC84DB1CF</gtr:id><gtr:title>A generalizable hypothesis for the genetic architecture of disease: pleomorphic risk loci.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c935c0efe5b22f529721363ec44ed6dd"><gtr:id>c935c0efe5b22f529721363ec44ed6dd</gtr:id><gtr:otherNames>Singleton A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm-16043-21875901</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A4B5FD-D876-4DC2-AED5-5EE4F756382B</gtr:id><gtr:title>Recursive splicing in long vertebrate genes.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3fd4c93bcc6764bb4a77247fb6ebec34"><gtr:id>3fd4c93bcc6764bb4a77247fb6ebec34</gtr:id><gtr:otherNames>Sibley CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>5675e46372905</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>714438DD-D805-4692-B478-1F4751175C07</gtr:id><gtr:title>Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35bdeaf16226f681b7918e3ebe21555f"><gtr:id>35bdeaf16226f681b7918e3ebe21555f</gtr:id><gtr:otherNames>Dickson DW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_16043_13_19909913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7A0D38B-85F8-461C-B431-82A4754D5907</gtr:id><gtr:title>Genome-wide association study of obsessive-compulsive disorder.</gtr:title><gtr:parentPublicationTitle>Molecular psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1dcf1f77d2e1df7ff7feb37ded9568a9"><gtr:id>1dcf1f77d2e1df7ff7feb37ded9568a9</gtr:id><gtr:otherNames>Stewart SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1359-4184</gtr:issn><gtr:outcomeId>pm_16043_23_22889921</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CCC89B16-681F-40FF-A48F-3040974F28E9</gtr:id><gtr:title>The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data.</gtr:title><gtr:parentPublicationTitle>Brain imaging and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/545bcb850f5bee6c4b4bb77b4df4cf03"><gtr:id>545bcb850f5bee6c4b4bb77b4df4cf03</gtr:id><gtr:otherNames>Thompson PM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1931-7557</gtr:issn><gtr:outcomeId>546cab59c0ba83.50394206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B31AEC4-7C7E-4086-A8A0-4AAC99E75BD4</gtr:id><gtr:title>Genetic variability in the regulation of gene expression in ten regions of the human brain.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>546caa919fdfb9.35212592</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F12C5775-7583-47B2-8A73-CBF5C1ED5340</gtr:id><gtr:title>Protected to death.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>pm-16043-20182050</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>81643BF0-77A2-46E6-81EF-5E41F640F83B</gtr:id><gtr:title>Integration of GWAS SNPs and tissue specific expression profiling reveal discrete eQTLs for human traits in blood and brain.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa0a98b877dd2fe06320fd79e75f4c4"><gtr:id>5fa0a98b877dd2fe06320fd79e75f4c4</gtr:id><gtr:otherNames>Hernandez DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>pm_16043_23_22433082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DAE8A32C-B951-4D2A-BB4A-AB028F40EF1E</gtr:id><gtr:title>Insights from cerebellar transcriptomic analysis into the pathogenesis of ataxia.</gtr:title><gtr:parentPublicationTitle>JAMA neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2168-6149</gtr:issn><gtr:outcomeId>pm_540e16de16d511914</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>723BE119-7AE1-4D26-954C-4ADE7117EF06</gtr:id><gtr:title>Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6883810a16e61c37ff340736f6cdf792"><gtr:id>6883810a16e61c37ff340736f6cdf792</gtr:id><gtr:otherNames>van Rheenen W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>5a6db8e4b60a86.50496712</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F22C99CA-983A-40E8-A630-76DD18CC9CF5</gtr:id><gtr:title>Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/609865d4dd5b805590a0ed599a30249b"><gtr:id>609865d4dd5b805590a0ed599a30249b</gtr:id><gtr:otherNames>Bras J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-003X</gtr:issn><gtr:outcomeId>pm_16043_23_22714018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA741AC9-4651-4829-A92F-744807B87D87</gtr:id><gtr:title>Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3617d8d8a839d289a3d354c415cb2d67"><gtr:id>3617d8d8a839d289a3d354c415cb2d67</gtr:id><gtr:otherNames>Lill CM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16043_23_22438815</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFCE2808-6EFC-4F1A-9210-F75FDBFD9C6F</gtr:id><gtr:title>Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_540e16de16d4748ed</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>516CEE12-2660-4003-8FDE-C3812C34844D</gtr:id><gtr:title>Identification of common variants associated with human hippocampal and intracranial volumes.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e9f254d9d808af1a43ce46fce3a313e"><gtr:id>9e9f254d9d808af1a43ce46fce3a313e</gtr:id><gtr:otherNames>Stein JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16043_23_22504417</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DF96E203-0CCF-44B3-878A-F4EEEFB4D567</gtr:id><gtr:title>Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2e8088f2d6e90105cd78b127c6516c9f"><gtr:id>2e8088f2d6e90105cd78b127c6516c9f</gtr:id><gtr:otherNames>Tucci A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>pm_16043_23_24198383</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A177459-5364-48C3-8B3A-42C3F7CB82D9</gtr:id><gtr:title>Genome-wide association study reveals genetic risk underlying Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/73f2f0764dd1bcc79b805b94497f0c43"><gtr:id>73f2f0764dd1bcc79b805b94497f0c43</gtr:id><gtr:otherNames>Sim?n-S?nchez J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_16043_13_19915575</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DFB1CC50-CBC5-4D12-B4FC-FE75E695CE8F</gtr:id><gtr:title>Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1bc530dea0f047a0508cb343a8ec2de"><gtr:id>c1bc530dea0f047a0508cb343a8ec2de</gtr:id><gtr:otherNames>Kasperaviciute D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>pm_540e16de16d2e6c83</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5E754FF-A517-42F8-B042-7C285423AA38</gtr:id><gtr:title>Major Shifts in Glial Regional Identity Are a Transcriptional Hallmark of Human Brain Aging.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a171f3d658cd96b7ebe3bcec8dea503c"><gtr:id>a171f3d658cd96b7ebe3bcec8dea503c</gtr:id><gtr:otherNames>Soreq L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58c7ccc56316a4.78832576</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7EDFB030-476D-41B4-99B3-BA946FAE418F</gtr:id><gtr:title>The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.</gtr:title><gtr:parentPublicationTitle>Journal of neurology, neurosurgery, and psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b45f75b0c7637f862f1b025d4b726505"><gtr:id>b45f75b0c7637f862f1b025d4b726505</gtr:id><gtr:otherNames>Klebe S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-3050</gtr:issn><gtr:outcomeId>546cb8c3c139a9.13738697</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FDA84EC2-AB7F-4B54-9727-78BFFF4DF429</gtr:id><gtr:title>Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.</gtr:title><gtr:parentPublicationTitle>Annals of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e46d4ee199e251c31c3a7a4780236cd5"><gtr:id>e46d4ee199e251c31c3a7a4780236cd5</gtr:id><gtr:otherNames>Holton P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0003-4800</gtr:issn><gtr:outcomeId>546cb5f9e77328.03003025</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22AF2957-B967-4815-9B95-B9F2AC432B52</gtr:id><gtr:title>Analysis of gene expression data using a linear mixed model/finite mixture model approach: application to regional differences in the human brain.</gtr:title><gtr:parentPublicationTitle>Bioinformatics (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1367-4803</gtr:issn><gtr:outcomeId>5675d9d2f0c2e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C6309179-EAB0-496B-B055-AA9961484157</gtr:id><gtr:title>Age-associated changes in gene expression in human brain and isolated neurons.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1a93647d799d53d5111001b3b241fdab"><gtr:id>1a93647d799d53d5111001b3b241fdab</gtr:id><gtr:otherNames>Kumar A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_16043_23_23177596</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2440BEEB-47D3-44EC-A43B-729B7C1186A2</gtr:id><gtr:title>Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16043_23_23967090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E47DDFA9-31DC-4702-A47A-01D8B019DD85</gtr:id><gtr:title>Investigating the utility of human embryonic stem cell-derived neurons to model ageing and neurodegenerative disease using whole-genome gene expression and splicing analysis.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7bf41e3616627e43c288596e8b1c932e"><gtr:id>7bf41e3616627e43c288596e8b1c932e</gtr:id><gtr:otherNames>Patani R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_16043_23_22681703</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87920CB3-57DB-407F-9D16-18C85CB3FE3D</gtr:id><gtr:title>Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf8b293c57e2abbe75629b0924e21ef0"><gtr:id>cf8b293c57e2abbe75629b0924e21ef0</gtr:id><gtr:otherNames>Nalls MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>546ca98db74359.95047972</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67C0312B-9A85-4503-8FCF-DF663FF75ACE</gtr:id><gtr:title>Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzymein multiple sclerosis.</gtr:title><gtr:parentPublicationTitle>Multiple sclerosis and related disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2211-0348</gtr:issn><gtr:outcomeId>546caa91cc4308.28919304</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5651BE9-37BF-49FA-A11A-6ABE44CCF6BE</gtr:id><gtr:title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_16043_23_22723018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90E3B663-6F7C-4AD0-8195-B9DB47A1FEB8</gtr:id><gtr:title>Widespread sex differences in gene expression and splicing in the adult human brain.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn><gtr:outcomeId>pm_16043_23_24264146</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>98FB18D2-4E31-4372-A959-888943761D6F</gtr:id><gtr:title>Loss of GPR3 reduces the amyloid plaque burden and improves memory in Alzheimer's disease mouse models.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a2c84b8517fcf40edbdb86bb7a02bba1"><gtr:id>a2c84b8517fcf40edbdb86bb7a02bba1</gtr:id><gtr:otherNames>Huang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>585d56f99c64e7.85613149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>47A8EF65-0C5D-41A9-88C0-4462D0786600</gtr:id><gtr:title>Resolving the polymorphism-in-probe problem is critical for correct interpretation of expression QTL studies.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>546cbd7f4bf4e9.96240497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6C88A348-D63A-404C-8B66-CCAE8F971609</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>mxLBFYchi1h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB391822-AE65-44FC-8A43-E2CEFBF30DA7</gtr:id><gtr:title>Gene co-expression networks shed light into diseases of brain iron accumulation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9960cd808582e52821f0e586e2ba9176"><gtr:id>9960cd808582e52821f0e586e2ba9176</gtr:id><gtr:otherNames>Bettencourt C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>585d689b3a5769.49891489</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1D168F5-E8E7-444B-8A7E-C186824F9240</gtr:id><gtr:title>Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad3f4aad48683e6e281e5a2c104a3d81"><gtr:id>ad3f4aad48683e6e281e5a2c104a3d81</gtr:id><gtr:otherNames>UK Parkinson's Disease Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm-16043-21044948</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90835192-CED7-4CD0-A7D4-133214F6EF08</gtr:id><gtr:title>Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f5fd8a036b6ccf0bb9a8fec23f69321d"><gtr:id>f5fd8a036b6ccf0bb9a8fec23f69321d</gtr:id><gtr:otherNames>Cruchaga C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>pm_540e16de16d3b55df</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B0B52108-1130-4C24-ADD8-0F396085B270</gtr:id><gtr:title>Frontotemporal dementia and its subtypes: a genome-wide association study.</gtr:title><gtr:parentPublicationTitle>The Lancet. Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1474-4422</gtr:issn><gtr:outcomeId>pm_540e16de16d60619f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E8B9837-0CC4-448A-9B58-2F24391D701A</gtr:id><gtr:title>Genomics implicates adaptive and innate immunity in Alzheimer's and Parkinson's diseases.</gtr:title><gtr:parentPublicationTitle>Annals of clinical and translational neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c20407c840fc3c52f1897ad927fd9e33"><gtr:id>c20407c840fc3c52f1897ad927fd9e33</gtr:id><gtr:otherNames>Gagliano SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2328-9503</gtr:issn><gtr:outcomeId>58c7cd69b360c2.22715024</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5849D134-17A9-400D-ACE6-D7821EA331EF</gtr:id><gtr:title>A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease</gtr:title><gtr:parentPublicationTitle>Human Molecular Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/11291e7208395859a2f8dbcb14e782d8"><gtr:id>11291e7208395859a2f8dbcb14e782d8</gtr:id><gtr:otherNames>Holmans P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>546cb5f9ba7b64.85828788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42558483-5117-4485-A2B4-27668AD447F0</gtr:id><gtr:title>Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f50f494061631e387b397ef9e7255462"><gtr:id>f50f494061631e387b397ef9e7255462</gtr:id><gtr:otherNames>Zou F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>pm_16043_23_22685416</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901254</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>